Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES:
I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function
and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis.